Treatment of nicotine addiction: A single-centre cohort study with cytisine
The Journal of Turkish Family Physician · 29.06.2026 · 17 (2) · 100-112
DOI: 10.15511/tjtfp.26.00200 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift The Journal of Turkish Family Physician, online erschienen am 29.06.2026. Verfasst von Fatma Gökşin Cihan und 4 weiteren Autor:innen.
Themen: Sucht und Abhängigkeit
Abstract (Originalsprache)
Aim
This study aimed to describe short- and mid-term smoking cessation outcomes, treatment discontinuation, relapse pattern, and self-reported side effects among patients who initiated cytisine treatment in a single university hospital smoking cessation clinic.
Methods
This prospective cohort study included patients who started treatment with cytisine at a university hospital smoking cessation clinic between 2 May and 31 December 2024. Patients were contacted by telephone at 1, 3 and 6 months to determine their smoking status. Nicotine dependence was measured using the Fagerström Test for Nicotine Dependence (FTND). Cigarette-Free Duration analysis was performed using the Kaplan–Meier method.
Results
The mean age of the 201 patients included in the study, who were followed up for six months, was 42.38 ± 15.01 years; 83.1% of these patients were male. Treatment was discontinued in 27.4% of patients on the fifth day due to failure to quit smoking. Smoking cessation rates were 72.6% on day 5, 43.3% after one month, 28.9% after three months and 21.4% after six months. Multivariate logistic regression analysis revealed that the presence of chronic disease was independently associated with successful smoking cessation at six months (OR = 6.60; 95% CI: 1.49–29.17; p = 0.013). The Kaplan–Meier analysis showed that treatment failures were concentrated particularly in the early period. Patients with an FTND score of ≥6 had a significantly shorter duration of smoking cessation (mean 71 days vs. 95 days; log-rank p=0.029).
Conclusion
Although smoking cessation treatment with cytisine can be successful in the short term, relapse is particularly common in the early stages. A high level of nicotine dependence reduces the length of time that a person can abstain from smoking. The higher success rate of quitting among individuals with chronic diseases suggests that smoking cessation counselling during primary care follow-ups for these diseases is an important opportunity. Providing intensive behavioural support in the early stages can increase the success of treatment.
Zitieren
APA
Cihan, F. G., Küçükceran, H., Demirbaş, N., Yaka, D., & Karaoğlu, N. (2026). Treatment of nicotine addiction: A single-centre cohort study with cytisine. The Journal of Turkish Family Physician, 17(2), 100-112. https://doi.org/10.15511/tjtfp.26.00200
Vancouver
Cihan FG, Küçükceran H, Demirbaş N, Yaka D, Karaoğlu N. Treatment of nicotine addiction: A single-centre cohort study with cytisine. The Journal of Turkish Family Physician. 2026;17(2):100-112. doi:10.15511/tjtfp.26.00200
BibTeX
@article{Cihan2026,
author = {Cihan, Fatma Gökşin and Küçükceran, Hatice and Demirbaş, Nur and Yaka, Derya and Karaoğlu, Nazan},
title = {Treatment of nicotine addiction: A single-centre cohort study with cytisine},
journal = {The Journal of Turkish Family Physician},
year = {2026},
volume = {17},
number = {2},
pages = {100--112},
doi = {10.15511/tjtfp.26.00200}
}
EUVIMED